Supplementary Table 1 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Composition and rates of all detectable genomic features detectable through the Caris diagnostic platform.

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Justin Hwang (15925675) (author)
Diğer Yazarlar:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes